Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03861065 · ClinicalTrials.gov registry record · NA

Secondary Versus Tertiary Wound Closure in High Risk Gynecologic Abdominal Surgical Incisions

A NA study, sponsored by Wake Forest University Health Sciences.

Terminated
Registry status
NA
Development phase
8
Enrollment target

NCT03861065: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.

NCT03861065 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03861065, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.

TERMINATED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

The purpose of this research study is to determine if closing a surgical wound differently is better than the procedure that is currently used. The wound will be closed with what is considered "tertiary intent." This means, rather than leaving the wound open, the wound will be partially closed after surgery, and then completely closed 4-7 days after surgery. The investigators also want to see how this new wound closure process affects your quality of life.

Primary Outcome

The number of surgical wounds that remained closed at postoperative day #30 after tertiary wound closure as compared to historical controls receiving a secondary wound closure.

Interventions

  • PROCEDURE Tertiary Wound Closure
  • PROCEDURE Historical Wound Closure

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2019-02-27
Est. Completion 2020-11-26
Phase NA
Wake Forest University Health Sciences

1,140 total trials

Why NCT03861065 stopped before completion

NCT03861065 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Tertiary Wound Closure is the first listed.

NCT03861065 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03861065 about?

NCT03861065 is a clinical study titled "Secondary Versus Tertiary Wound Closure in High Risk Gynecologic Abdominal Surgical Incisions". The purpose of this research study is to determine if closing a surgical wound differently is better than the procedure that is currently used. The wound will be closed with what is considered "tertiary intent." This means, rather than leaving the wound open, the wound will be partially closed after...

What is the current status of trial NCT03861065?

This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2019-02-27. Estimated completion is 2020-11-26.

What interventions are being tested in trial NCT03861065?

The interventions under investigation include: Tertiary Wound Closure (PROCEDURE), Historical Wound Closure (PROCEDURE).

Who is sponsoring clinical trial NCT03861065?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03861065's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03861065, the US trial registry maintained by the National Library of Medicine. NCT03861065 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.